ACSH In The Wall Street Journal: Why Drug 'Reimportation' Won't Die

By ACSH Staff — Jan 08, 2010
American Council on Science and Health Medical Director Dr. Gil Ross writes an article in the Wall Street Journal on drug "reimportation." Why is drug importation (and its twin the reimportation of American drugs from foreign countries) a bad idea? Aren't cheaper drugs good for low-income Americans?

American Council on Science and Health Medical Director Dr. Gil Ross writes an article in the Wall Street Journal on drug "reimportation."

Why is drug importation (and its twin the reimportation of American drugs from foreign countries) a bad idea? Aren't cheaper drugs good for low-income Americans?

The Food and Drug Administration's response reasserted last month by FDA Commissioner Margaret Hamburg is that imported and reimported drugs can't be guaranteed to be safe. Studies have shown that a significant percentage of drugs thought to be American-made and reimported are actually counterfeit, ineffective or even toxic.

ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!

 

 

Popular articles